Bupropion and Cognitive Behavioral Therapy for Weight-Concerned Women Smokers

被引:60
作者
Levine, Michele D. [1 ]
Perkins, Kenneth A. [1 ]
Kalarchian, Melissa A. [1 ]
Cheng, Yu [2 ,3 ]
Houck, Patricia R. [1 ]
Slane, Jennifer D. [4 ]
Marcus, Marsha D. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[4] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA
关键词
SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; NICOTINE GUM; GAIN; PREVENTION; TRIAL;
D O I
10.1001/archinternmed.2010.33
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We previously documented that cognitive behavioral therapy for smoking-related weight concerns (CONCERNS) improves cessation rates. However, the efficacy of combining CONCERNS with cessation medication is unknown. We sought to determine if the combination of CONCERNS and bu-propion therapy would enhance abstinence for weight-concerned women smokers. Methods: In a randomized, double-blind, placebo-controlled trial, weight-concerned women (n =349; 86% white) received smoking cessation counseling and were randomized to 1 of 2 adjunctive counseling components: CONCERNS or STANDARD (standard cessation treatment with added discussion of smoking topics but no specific weight focus), and 1 of 2 medication conditions: bu-propion hydrochloride sustained release (B) or placebo (P) for 6 months. Rates and duration of biochemically verified prolonged abstinence were the primary outcomes. point-prevalent abstinence, postcessation weight gain, and changes in nicotine withdrawal, depressive symptoms, and weight concerns were evaluated. Results: Women in the CONCERNS + B group had higher rates of abstinence (34.0%) and longer time to relapse than did those in the STANDARD + B (21%; P = .05) or CONCERNS + p (11.5%; P = .005) groups at 6 months, although rates of prolonged abstinence in the CONCERNS + B and STANDARD + B groups did not differ significantly at 12 months. Abstinence rates and duration did not differ in the STANDARD + B group (21% and 19%) compared with the STANDARD + P group (10% and 7%) at 6 and 12 months, respectively. There were no difference among abstinent women in postcessation weight gain or weight concerns, although STANDARD + B produced greater decreases in nicotine withdrawal and depressive symptoms than did STANDARD + P. Conclusions:Weight-concerned women smokers receiving the combination of CONCERNS + B were most likely to sustain abstinence. This effect was not related to differences in postcessation weight gain or changes in weight concerns.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 25 条
  • [1] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [2] Reliability and validity of a smoking timeline follow-back interview
    Brown, RA
    Burgess, ES
    Sales, SD
    Evans, DM
    Miller, IW
    [J]. PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 1998, 12 (02) : 101 - 112
  • [3] The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion
    Catley, D
    Harris, KJ
    Okuyemi, KS
    Mayo, MS
    Pankey, E
    Ahluwalia, JS
    [J]. NICOTINE & TOBACCO RESEARCH, 2005, 7 (06) : 859 - 870
  • [4] Fairburn Christopher G., 1993, P361
  • [5] WEIGHT-GAIN PREVENTION AND SMOKING CESSATION - CAUTIONARY FINDINGS
    HALL, SM
    TUNSTALL, CD
    VILA, KL
    DUFFY, J
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (06) : 799 - 803
  • [6] NICOTINE GUM AND BEHAVIORAL TREATMENT IN SMOKING CESSATION
    HALL, SM
    TUNSTALL, C
    RUGG, D
    JONES, RT
    BENOWITZ, N
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1985, 53 (02) : 256 - 258
  • [7] Hays JT, 2003, MAYO CLIN PROC, V78, P1020
  • [8] Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation - A randomized, controlled trial
    Hays, JT
    Hurt, RD
    Rigotti, NA
    Niaura, R
    Gonzales, D
    Durcan, MJ
    Sachs, DPL
    Wolter, TD
    Buist, AS
    Johnston, JA
    White, JD
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (06) : 423 - 433
  • [9] Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552
  • [10] A comparison of sustained-release bupropion and placebo for smoking cessation
    Hurt, RD
    Sachs, DPL
    Glover, ED
    Offord, KP
    Johnston, JA
    Dale, LC
    Khayrallah, MA
    Schroeder, DR
    Glover, PN
    Sullivan, CR
    Croghan, IT
    Sullivan, PM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (17) : 1195 - 1202